- Home
- KALA vs XOS Comparison
KALA vs XOS Comparison
Compare KALA & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- XOS
- Stock Information
- Founded
- KALA 2009
- XOS 2016
- Country
- KALA United States
- XOS United States
- Employees
- KALA N/A
- XOS N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- XOS Construction/Ag Equipment/Trucks
- Sector
- KALA Health Care
- XOS Consumer Discretionary
- Exchange
- KALA Nasdaq
- XOS Nasdaq
- Market Cap
- KALA 26.2M
- XOS 25.6M
- IPO Year
- KALA 2017
- XOS N/A
- Fundamental
- Price
- KALA $5.16
- XOS $3.30
- Analyst Decision
- KALA Strong Buy
- XOS Buy
- Analyst Count
- KALA 3
- XOS 5
- Target Price
- KALA $14.00
- XOS $8.80
- AVG Volume (30 Days)
- KALA 71.9K
- XOS 20.2K
- Earning Date
- KALA 08-05-2025
- XOS 08-12-2025
- Dividend Yield
- KALA N/A
- XOS N/A
- EPS Growth
- KALA N/A
- XOS N/A
- EPS
- KALA N/A
- XOS N/A
- Revenue
- KALA N/A
- XOS $48,678,000.00
- Revenue This Year
- KALA N/A
- XOS $1.45
- Revenue Next Year
- KALA N/A
- XOS $27.16
- P/E Ratio
- KALA N/A
- XOS N/A
- Revenue Growth
- KALA N/A
- XOS N/A
- 52 Week Low
- KALA $2.92
- XOS $2.73
- 52 Week High
- KALA $11.20
- XOS $9.15
- Technical
- Relative Strength Index (RSI)
- KALA 61.92
- XOS 56.65
- Support Level
- KALA $4.36
- XOS $3.00
- Resistance Level
- KALA $5.75
- XOS $3.15
- Average True Range (ATR)
- KALA 0.53
- XOS 0.11
- MACD
- KALA 0.07
- XOS 0.04
- Stochastic Oscillator
- KALA 64.39
- XOS 84.41
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About XOS Xos Inc.
Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Classes 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.